Azerbaijan vs Colombia: Cause of death, by non-communicable diseases, female
Azerbaijan
66.8%
in 2021
Colombia
66.3%
in 2021
Azerbaijan rank
102nd
Colombia rank
104th
Cause of death, by non-communicable diseases, female over time
- Azerbaijan
- Colombia
How they compare
Azerbaijan currently reports 66.8% against 66.3% in Colombia, a difference of 0.5%.
Across all 6 years both countries report, Azerbaijan has been ahead every year.
Azerbaijan ranks 102nd and Colombia ranks 104th of 185 countries.
Azerbaijan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Azerbaijan | Colombia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 80.7% | 75.7% | 5.0% | Azerbaijan |
| 2010s | 89.7% | 83.8% | 5.9% | Azerbaijan |
| 2020s | 71.9% | 69.9% | 2.0% | Azerbaijan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, Azerbaijan or Colombia?
- Azerbaijan, at 66.8% against 66.3% in Colombia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between Azerbaijan and Colombia?
- 0.5%, with Azerbaijan ahead.
- How many years of comparable data are there for Azerbaijan and Colombia?
- 6 years are reported by both, from 2000 to 2021.
- How do Azerbaijan and Colombia rank globally for cause of death, by non-communicable diseases, female?
- Azerbaijan ranks 102nd and Colombia ranks 104th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.